Cite
Fisher BT, Sammons JS, Li Y, et al. Variation in Risk of Hospital-Onset Clostridium difficile Infection Across β-Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia. J Pediatric Infect Dis Soc. 2014;3(4):329-35doi: 10.1093/jpids/piu008.
Fisher, B. T., Sammons, J. S., Li, Y., de Blank, P., Seif, A. E., Huang, Y. S., Kavcic, M., Klieger, S., Harris, T., Torp, K., Rheam, D., Shah, A., & Aplenc, R. (2014). Variation in Risk of Hospital-Onset Clostridium difficile Infection Across β-Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia. Journal of the Pediatric Infectious Diseases Society, 3(4), 329-35. https://doi.org/10.1093/jpids/piu008
Fisher, Brian T, et al. "Variation in Risk of Hospital-Onset Clostridium difficile Infection Across β-Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia." Journal of the Pediatric Infectious Diseases Society vol. 3,4 (2014): 329-35. doi: https://doi.org/10.1093/jpids/piu008
Fisher BT, Sammons JS, Li Y, de Blank P, Seif AE, Huang YS, Kavcic M, Klieger S, Harris T, Torp K, Rheam D, Shah A, Aplenc R. Variation in Risk of Hospital-Onset Clostridium difficile Infection Across β-Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia. J Pediatric Infect Dis Soc. 2014 Dec;3(4):329-35. doi: 10.1093/jpids/piu008. Epub 2014 Feb 16. PMID: 26625453; PMCID: PMC4854370.
Copy
Download .nbib